Igenomix is a global biotechnology company specializing in reproductive genetics, providing diagnostic tests and research services for clinical fertility.
Company context
Igenomix prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
Igenomix is a global leader in reproductive genetics, dedicated to providing advanced diagnostic services that improve the success rates of assisted reproduction. Founded in 2011 as a spin-out from the Instituto Valenciano de Infertilidad (IVI), the company has grown into a worldwide network of over 20 laboratories serving clinics and patients in more than 80 countries. Their work focuses on the entire reproductive journey, offering specialized testing for preconception, pre-implantation, and prenatal stages to help couples achieve healthy pregnancies.
Igenomix’s mission is to make infertility no longer an impossible barrier, working with clinics and fertility doctors to investigate human reproduction to help couples achieve the goal of a 'healthy baby at home.'
Founded
2011
Headquarters
Valencia, Spain
Employees
1,000-5,000
Industry
Biotech / Diagnostics
Strong emphasis on scientific research and innovation.
Opportunity to work with cutting-edge genetic diagnostic technologies.
Global presence provides exposure to international clinical standards.
High-pressure environment due to the critical nature of clinical diagnostic timelines.
Funding
Acquired by Vitrolife Group in 2021
CEO
Thomas Axelsson (CEO of Vitrolife Group)
Corporate integration following the Vitrolife acquisition may lead to organizational changes.